New study tests misoprostol to cut bleeding in fibroid surgery
NCT ID NCT06882824
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This study tests whether a single dose of misoprostol, a medication often used in gynecology, can reduce blood loss during surgery to remove uterine fibroids (myomectomy). About 80 women aged 18-43 with symptomatic fibroids will receive either misoprostol or a placebo before surgery. The goal is to see if this simple, well-tolerated drug can make the operation safer by lowering the risk of heavy bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOMA;UTERUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Clermont-Ferrand
RECRUITINGClermont-Ferrand, Clermont-Ferrand, 63000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.